Saudi Diabetes Summit 2025
Innovation in Diabetes Care: Towards a Healthy Kingdom
- Riyadh, KSA
Event overview
The Kingdom of Saudi Arabia ranks the second highest in the Middle East and is seventh in the world for the rate of diabetes.
With 7 million population having diabetes and 3 million pre-diabetic cases in the kingdom, there is a rising burden of diabetes-related complications like heart disease, blindness, and amputations impacting almost one in five adults. Addressing the unique challenges of diabetes management in Saudi Arabia, it is crucial to reshape the narrative of diabetes care in the Kingdom and build a healthier future for generations to come.
In line with the vision of the Saudi Ministry of Health 2030, it is our great delight to bring to you the Saudi Diabetes Summit 2025, a platform where we unite with healthcare professionals specializing in Diabetes Care to ignite a movement towards a future where diabetes is no longer a barrier to a fulfilling life. Join us as we discuss innovative strategies for empowering patients and communities to take control of their health and explore cutting-edge advancements in diabetes prevention, diagnosis, and treatment.
Why Attend
Join us at the Saudi Diabetes Summit 2025, where we address the pressing issue of diabetes prevalence in Saudi Arabia. Given that one in ten people in Saudi Arabia are now living with diabetes and the prevalence of the disease will almost double in the Kingdom by 2045.
Our summit is more than just a conference; it’s a platform for action-driven conversations, groundbreaking research, and intelligent investments. Together, we’ll fuel thought-provoking discussions to promote innovation and healing in diabetes care.
Be part of the movement to reshape the future of diabetes in the Kingdom. Join us at the Saudi Diabetes Summit 2025 and unlock the potential of a healthier future, together.
Topic Highlights
Diabetes in Saudi Arabia: Current Status, Emerging Trends, and Future Directions
Mobile Applications and Wearable Devices for Diabetes Management
Utilizing Big Data Analytics for Population Health Management in Diabetes
Next-Generation Insulin Therapies: Improving Efficacy and Safety
Role of Artificial Intelligence and Machine Learning in Personalized Diabetes Management
Innovations in Diabetes Diagnosis: From Biomarkers to Digital Health Solutions
Advances in Insulin Delivery Systems: Insulin Pumps, Patch Pumps, and Smart Insulin Pens
Role of Telemedicine and Remote Patient Monitoring in Diabetes Care
Whom Will You Meet
Why Sponsor
The Saudi Diabetes Summit 2025 presents the perfect opportunity for solution providers to engage with key decision-makers within the healthcare domain in the Kingdom of Saudi Arabia to differentiate their products and put forward their value proposition in this emerging marketplace. Some of the key reasons why you should sponsor:
-
Demonstrate Thought Leadership
Position your company as a thought leader by delivering a standalone presentation or moderating a panel discussion to a pre-qualified audience comprising decision-makers.
-
Network & Generate Leads
Optimize your networking opportunities by getting right in front of key decision-makers that are prequalified based on seniority, budget availability, and motivation to learn about the latest innovations
-
Brand Positioning
Establish, strengthen and re-position your brand in front of MDs and GMs who are looking to re-align and strengthen their digital transformation strategies.
News and Articles
WHO issues warnings on fake diabetes and weight-loss drugs
DUBAI: The World Health Organization (WHO) on Thursday issued warnings on falsified semaglutides used in diabetes and weight-loss drugs in light of three altered batches of products detected in Brazil, the UK and the United States. . . . . . . . . . . .
Saudi center sets Guinness World Record for diabetes awareness
Riyadh: Saudi Arabia’s Minister of Health Fahad Al-Jalajel received a Guinness World Record certificate for the Diabeter Center in Al-Ahsa, which specializes in treating Type 1 diabetes patients.
The center achieved the record for the largest simultaneous human gathering for diabetes awareness and education, bringing together 752 people, the Saudi Press Agency reported on Sunday……………..
Saudi Arabia’s looming diabetes disaster
Over the next ten years, one in four Saudis will be at risk of having a fatal heart attack, according to a study by a team of researchers led by Muhammad Adil Soofi, assistant consultant in the adult cardiology department at Prince Salman Heart Center, King Fahad Medical City in Riyadh.
Of the 4,900 urban-dwelling Saudis monitored by the team, 26% were at high risk of having a heart attack in the next decade. Those in the cohort did not have a history of cardiovascular diseases (CVD), and were between the ages of 20 and 40.
These alarming results were presented last week at the 26th Annual Conference of the Saudi Heart Association.
MENA has highest prevalence of diabetes
LONDON: The Middle East and North Africa region has the highest prevalence of diabetes, research has revealed, with Kuwait and Egypt among the top 10 countries for rates of the condition worldwide in 2021, the Daily Mail reported on Tuesday.
The figures from Our World In Data used information from the International Diabetes Federation to measure the prevalence of diabetes among populations aged 20-79 in 211 countries……………….
Prevalence of diabetes in Saudi Arabia to almost double by 2045: Report
More than one in ten people in Saudi Arabia are now living with diabetes and the prevalence of the disease will almost double in the Kingdom by 2045, according to a new report by the International Diabetes Federation (IDF)
The IDF report revealed that 4.274.1 million people in Saudi Arabia – which has a population of about 34.8 million according to latest statistics by the Worldometer – have diabetes, while a further 1.863.5 million people have the disease but are yet to be diagnosed…………………..
Diabetes drugs like Ozempic lower cancer risks: study
WASHINGTON: A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Published in the journal JAMA, the study compared patients with Type 2 diabetes who were treated with insulin versus patients who were given a class of drug known as GLP-1 agonists, like Ozempic, between 2005 and 2018…………….
How a Saudi healthcare startup is using AI to transform the diagnosis of chronic diseases
RIYADH: Healthcare startup SDM is using artificial intelligence to make healthcare efficient, accessible and potentially life-saving by detecting the stages of chronic diseases such as diabetes through retinal imaging analysis of the eye.
“When you hear the phrase ‘your eye is a window to your body,’ it’s actually the retina that is the window to any systemic diseases,” Dr. Selwa Al-Hazzaa, CEO and founder of SDM, told Arab News……………
Reducing diabetes spread starts with education
JEDDAH/RIYADH: Saudi schools, hospitals, and universities are marking World Diabetes Day on Nov. 14 with education campaigns on the disease’s health risks and its potential to kill.
Around 73 million people in the Middle East and North Africa have been diagnosed with diabetes. That number is forecast to balloon to 135.7 million by 2045…………………
Boehringer, Alpha to locally make type 2 diabetes medicine
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, has successfully transferred the manufacturing operations of one of its innovative medicines for the treatment of type 2 diabetes to Alpha Pharma in Saudi Arabia. This announcement follows Boehringer’s 2023 MoU with the Ministry of Investment, focusing on boosting cooperation in pharmaceutical localization and knowledge transfer to enhance the health of communities in the Kingdom. The collaboration with the leading Saudi pharmaceutical manufacturer, Alpha Pharma, will combat type 2 diabetes in the Kingdom and is fully aligned with the Kingdom’s Vision 2030 goals…………….
Biocon in pact with Tabuk Pharma to sell diabetes drugs in Middle East
Biotechnology firm Biocon Ltd on Thursday (September 26) said it has entered into a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company, a subsidiary of Astra Industrial Group, to commercialise its glucagon-like peptide-1 (GLP-1) products in the Middle East…….
Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing
Biocon Ltd on Thursday said it has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company to commercialise its ‘GLP-1’ products for treating diabetes and chronic weight management in select countries of the Middle East…………
Learn how healthcare systems in Saudi Arabia
Saudi Arabia and the United Arab Emirates (UAE) are two Gulf nations witnessing an explosive growth in the prevalence and incidence of diabetes, having some of the highest rates in the world. According to 2019 reports, prevalence is as high as nearly one in five adults (18.3%) in Saudi Arabia and about one in six adults (15.4%) in the UAE. Telemedicine has been an important part of care in these countries’ evolving healthcare services to keep affected patients healthy and costs down. ………
Smit.fit and Droobi Health Merge to Establish DroobiSmit: Dominating Digital Diabetes Solutions in MENA/GCC and South Asia
Smit.fit, a frontrunner in India’s digital health landscape, and Droobi Health, a leading digital diabetes player in the Middle East from Doha, Qatar, have merged to form DroobiSmit with its headquarters in Singapore. This strategic move positions DroobiSmit as the premier digital diabetes solution provider across the MENA/GCC and South Asia regions, with support from key investors, including Qatar Development Bank (QDB), Qatar Science and Technology Park (QSTP), and M-venture (MVP) in Singapore…………
Diabetes: Saudi Arabia’s growing health problem
DUBAI: Saudi Arabia is aiming to defuse its diabetes time bomb by reducing the prevalence of the disease by 10 percent over the next decade, with a new report warning of the crippling economic and social burdens the illness
is placing on the region.
While several Middle East countries have a roadmap to stem a crisis that threatens to overwhelm health-care systems — with Saudi Arabia highlighted as a key example — the region is experiencing what is “potentially the greatest epidemic in human history,” according to an in-depth report on diabetes in MENA by advisory firm Colliers International……
Health Ministry partners with Ithnain to transform diabetes care
In a landmark initiative poised to transform diabetes management across the Kingdom, the Saudi Ministry of Health has formalized an MoU with Ithnain, an online healthcare coaching startup. The partnership underscores the pivotal role of innovation in addressing healthcare challenges and highlights the capacity of Saudi enterprises to contribute to the nation’s ambitious Vision 2030.
The MoU was signed by Dr. Abdullah Alsoheimi, general director of Specialized Centers Affairs at the Ministry of Health, and Meshari Althowaini, CFO at Ithnain…….
Saudis move to fight diabetes, the silent killer
JEDDAH: The Saudi Sports for All Federation (SFA) is raising awareness and promoting a health program ahead of World Diabetes day on Nov. 14.
Diabetes is one of the most common chronic diseases related to aging — significant as Saudi Arabia’s adult population is rising above 23 million. According to the International Diabetes Federation, the prevalence of diabetes in adults is 18.3 percent (more than 4 million cases), related to lifestyle issues such as lack of exercise, an unhealthy diet and obesity.
According to a WHO report, Saudi Arabia is ranked the second highest in the Middle East and seventh in the world for the rate of diabetes………….
Saudi telecoms firm in deal to provide vital eye-screening tests for diabetes in Kingdom
RIYADH: Saudi telecommunications firm stc has signed a deal with a health technology company to provide vital checks for eye problems caused by diabetes.
SDM’s screening technology not only identifies if patients have the blood sugar condition but also notifies them of what stage the disease has reached and if medical intervention is required.
Tension,diabetes common among Indians in Saudi Arabia
Diabetes and hypertension are the most common health disorders among the Indian expatriates living in Saudi Arabia,a team of doctors in Riyadh have said.
The doctors examined around 650 Indian expatriates,mostly from Kerala,who turned up for free health check up at a camp organised by a social organisation on last Friday,Saudi Gazette reported.
